Search
for
Sort by
Research 451–480 of 1000+
- Bimatoprost for the treatment of eyelash, eyebrow and scalp alopecia
- New Treatment Options for Alopecia Areata
- Medicaid coverage of Janus kinase inhibitors for alopecia areata treatment
- DUTASTERIDE AS AN EFFECTIVE TREATMENT IN ANDROGENETIC ALOPECIA – A LITERATURE REVIEW
- Testosterone Treatment in Women – An Overview
- A Real‐World Disproportionality Analysis of Avacopan in Anti‐Neutrophil Cytoplasmic Antibodies Associated Vasculitis: Insights From FDA Adverse Event Reporting System
- Treatment options for alopecia: an update, looking to the future
- Real-world study of adverse events associated with gepant use in migraine treatment based on the VigiAccess and U.S. Food and Drug Administration’s adverse event reporting system databases
- Cepharanthine: a review of the antiviral potential of a Japanese-approved alopecia drug in COVID-19
- Safety profile of ipilimumab in elderly patients: a disproportionate analysis based on the FDA Adverse Event Reporting System database
- Comprehensive Study of Drug-Induced Pruritus Based on Adverse Drug Reaction Report Database
- Public Interest in JAK Inhibitors for Alopecia Areata: A Google Trend Analysis (Preprint)
- Alopecia Areata: An Updated Review for 2023
- Safety Assessment of Ritlecitinib Based on the FDA Adverse Event Reporting System (FAERS) Database: A Real‐World Pharmacovigilance Study
- The Alopecia Areata Investigator Global Assessment scale: a measure for evaluating clinically meaningful success in clinical trials
- Physical Treatments and Therapies for Androgenetic Alopecia
- Ritlecitinib: Efficacy of a Novel Therapy for Severe Alopecia Areata in Patients Aged 12 Years and Older
- Alopecia – New building blocks
- Delivery Strategies of siRNA Therapeutics for Hair Loss Therapy
- Can oral minoxidil be the game changer in androgenetic alopecia? A comprehensive review and meta-analysis comparing topical and oral minoxidil for treating androgenetic alopecia
- Persistent Sexual Dysfunction and Suicidal Ideation in Young Men Treated with Low-Dose Finasteride: A Pharmacovigilance Study
- Hydroxychloroquine and Chloroquine in Prophylaxis and Treatment of COVID-19
- Upadacitinib in dermatologic therapy: Emerging evidence and expanding indications
- Investigating tralokinumab-related adverse events in treating atopic dermatitis: insights from the FAERS database
- Alopecia After Switch to Tenofovir Alafenamide in 6 African American Women
- Unraveling Ritlecitinib: an in-depth analysis of JAK3 inhibitor for the treatment of alopecia areata
- Exploring the historical stigma of spironolactone use in breast cancer survivors with alopecia
- Response: Finasteride's Effect on Frontal and Vertex Hair Loss
- Minoxidil tópico o minoxidil oral en la alopecia. ¿Cuál es su elección?
- Multidimensional assessment of adverse events of finasteride:a real-world pharmacovigilance analysis based on FDA Adverse Event Reporting System (FAERS) from 2004 to April 2024